Bill builds on Senate’s work to reduce prescription drug costs, promote transparency, and increase patient access
BOSTON (02/03/2022) – Today, the Massachusetts Senate unveiled An Act relative to Pharmaceutical Access, Costs and Transparency (PACT Act 2022), comprehensive pharmaceutical cost control legislation aimed at addressing the rapidly increasing costs of prescription drugs. By connecting the need for greater drug price transparency with policies to improve oversight for the pharmaceutical industry, the legislation puts the Senate at the forefront of the state’s efforts to tackle rapidly increasing prescription drug costs. It will also reduce drug costs for patients and lower health care costs overall.
“No one should ever have to choose between buying life-saving drugs like insulin and being able to pay rent,” said Senate President Karen E. Spilka (D-Ashland). “Two years into the COVID-19 pandemic, people are more aware than ever of the need for equitable access to quality health care and being able to afford necessary medication is a key component of this. This bill provides direct relief to consumers and tackles the systematic drivers of high drug prices to reduce health care costs for patients across the Commonwealth. I am proud of the long-standing efforts of the Senate to reform prescription drug costs, particularly those initiated by Senator Cindy Friedman, Chair of the Health Care Financing Committee, and I look forward to getting this bill signed into law.”
“Our goal for health care is to create a system that delivers affordable, high quality and accessible care to all of our residents,” said Senator Cindy F.… Read more.